Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

SOTIO Biotech a.s.

Czechia Ceskomoravska 2532/19b Liben, 190 00 Prague, Czechia

About the sponsor

SOTIO Biotech a.s. focuses on advanced gastric adenocarcinoma and adenocarcinoma of the gastroesophageal junction, with research centred on treatment options for gastrointestinal malignancies that remain difficult to manage in later-stage disease.

  • Gastric adenocarcinoma
  • Gastroesophageal junction adenocarcinoma
  • Advanced solid tumours

Its clinical interest in this area is directed toward tumour control in upper gastrointestinal cancers and the evaluation of novel targeted oncology approaches.

About Specializations

SOTIO Biotech a.s. runs clinical trials in conditions such as Colorectal cancer, Oesophageal adenocarcinoma, Adenocarcinoma pancreas, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Colorectal cancer

Not yet recruiting

A phase 1/2 study evaluating safety, pharmacokinetics and efficacy of SOT109 in patients with advanced unresectable or metastatic colorectal cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:SOTIO Biotech a.s.

Oesophageal adenocarcinoma+1

Not recruiting

Study on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:SOTIO Biotech a.s.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.